-
Sanofi Sells Rare Disease Monoclonal Antibody Drug
Sanofi
Sanofi sells rights to Enjaymo?, a rare disease monoclonal antibody drug, to Recordati for up to $1.1 billion. The deal boosts Recordati's rare disease portfolio while Sanofi shifts focus to immunology and inflammation. Enjaymo treats cold agglutinin disease (CAD).
南漳县|
尼玛县|
利辛县|
赤峰市|
铜川市|
永安市|
麟游县|
亳州市|
阳原县|
广安市|
潞城市|
桑植县|
昌江|
武城县|
巩留县|
会昌县|
札达县|
安徽省|
腾冲县|
临漳县|
乐平市|
彝良县|
隆尧县|
连云港市|
思茅市|
时尚|
天长市|
长宁县|
吉隆县|
喀喇|
呼伦贝尔市|
探索|
启东市|
广德县|
南召县|
石首市|
海南省|
遂宁市|
绥江县|
攀枝花市|
高陵县|